I also donated all of my shares in Weight Watchers to the Smithsonian Museum of African American History and Culture so that I could have a conversation with you, Sima. During a quick interview with Sistani, the Weight Watchers CEO discussed why the brand recently began offering weight loss medication as part of its membership plan
Exploring the Potential of GLP-1 Agonists as MASH/MAFLD Treatment. ScienceDirect , 2024, www.sciencedirect.com/science/article/pii/S1542356524001605
Retatrutide: Designed to Last One of the newest GLP-1 medications in development is retatrutide , a triple agonist (GLP-1, GIP, and glucagon receptors) designed with an approximate 6-day half-life , thanks to advanced pharmaceutical engineering
Glucagon-like peptide-1 (GLP-1) agonists, which improve insulin secretion, decrease glucagon secretion, increase satiety (and therefore decrease food intake), and may have beneficial effects on beta-cell function, represent an important addition to treatment options
ArticlePubMed 4